Table 3.

Univariate analysis for the clinical factors of SARS-CoV-2 infection.

Characteristics	OR	95%CI	P value
Age ≥ 38, n (%)	2.325	0.959 to 5.858	0.066
Male, n (%)	0.72	0.281 to 1.773	0.481
CCI score ≥ 2, n (%)	0.644	0.219 to 1.971	0.427
ECOG ≥ 2, n (%)	1.151	0.441 to 3.185	0.778
UDCA prophylaxis, n (%)	0.889	0.224 to 3.013	0.856
Disease, n (%)
ALL	Ref.	Ref.	–
AML	1.129	0.362 to 3.465	0.831
MDS	0.659	0.159 to 2.732	0.565
Other	0.874	0.252 to 3.036	0.832
Disease status before transplant, n (%)
Early/low	Ref.	Ref.	–
Intermediate	0.938	0.14 to 6.28	0.947
High/Advanced	1.05	0.177 to 6.22	0.957
Auxiliary UCBT, n (%)	1.815	0.448 to 7.353	0.475
Donor-recipient sex match, n (%)
Female-Male	1.224	0.406 to 12.727	0.730
Transplant types, n (%)
MSD	Ref.	Ref.	–
HID	0.614	0.231 to 1.629	0.327
URD	0.222	0.031 to 1.578	0.133
Engraftment post transplantation, n (%)
Neutrophil	2.107	0.243 to 18.308	0.468
Platelet	1.187	0.29 to 4.299	0.798
Acute GVHD, n (%)	1.056	0.414 to 2.815	0.911
Time after transplantation, n (%)
≥ 3 months	3.241	1.287 to 8.814	0.016

OR, Odds Ratio; CI, Confidence Interval.

Significant difference (P < 0.05) is bolded.